Sergio Almenar

Randomized Phase 3 Trial of Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast Cancer

Miguel Martín, Álvaro Rodríguez-Lescure, A. Ruiz et al. · JNCI Journal of the National Cancer Institute · 2008 · 238 citations · Full text

Clinicopathological and immunohistochemical analysis of 20 cases of Merkel cell carcinoma in search of prognostic markers

B. Llombart, Carlos Monteagudo, José Antonio López‐Guerrero et al. · Histopathology · 2005 · 218 citations · Full text

Adjuvant Docetaxel for High-Risk, Node-Negative Breast Cancer

Miguel Martín, Miguel Ángel Seguí, Antonio Antón et al. · New England Journal of Medicine · 2010 · 208 citations · Full text

THE 3-MONTH CLINICAL RESPONSE TO INTRAVESICAL THERAPY AS A PREDICTIVE FACTOR FOR PROGRESSION IN PATIENTS WITH HIGH RISK SUPERFICIAL BLADDER CANCER

E. Solsona, I. Iborra, R. Dumont et al. · The Journal of Urology · 2000 · 188 citations

Dermatofibrosarcoma protuberans: clinical, pathological, and genetic (<i>COL1A1‐PDGFB </i>) study with therapeutic implications

B. Llombart, Onofre Sanmartín, José Antonio López‐Guerrero et al. · Histopathology · 2009 · 101 citations · Full text